Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				AGENDA GM307, NCT00518895


2.		Abraxane and Temodar Plus Genasense in Advanced Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				GM108 NCT00409383


3.		Genasense as a 2-Hour Intravenous Infusion in Subjects With Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				GPK109 NCT00636545

First Published: 8/13/2008


4.		Pilot Study of Microarray-Directed Therapy Comprising Oblimersen and Standard CHOP-R in Patients With Newly Diagnosed Stage I-IV Diffuse Large B-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				19 and over				NCI				UNMC-46207 UNMC 462-07, NCT00736450

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute